Kang MH - Search Results

1

API-2-Induced Cell Migration Is Overcome by Small Molecular Approaches Inhibiting β-Catenin.

Kim Y, Kang MH, Cho YH. Kim Y, et al. Among authors: kang mh. Curr Issues Mol Biol. 2022 Nov 29;44(12):6006-6014. doi: 10.3390/cimb44120409. Curr Issues Mol Biol. 2022. PMID: 36547070 Free PMC article.

2

Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer.

Choi YJ, Lee H, Kim DS, Kim DH, Kang MH, Cho YH, Choi CM, Yoo J, Lee KO, Choi EK, Lee JC, Rho JK. Choi YJ, et al. Among authors: kang mh. Eur J Pharmacol. 2021 Sep 15;907:174298. doi: 10.1016/j.ejphar.2021.174298. Epub 2021 Jul 3. Eur J Pharmacol. 2021. PMID: 34224696

3

BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.

Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA. Kang MH, et al. Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14. Exp Cell Res. 2010. PMID: 19835871

4

Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.

Kang MH, Oh SC, Lee HJ, Kang HN, Kim JL, Kim JS, Yoo YA. Kang MH, et al. Among authors: kang hn. Exp Cell Res. 2011 Jul 15;317(12):1746-62. doi: 10.1016/j.yexcr.2011.04.006. Epub 2011 Apr 30. Exp Cell Res. 2011. PMID: 21570392

5

Efficacy of the CDK7 Inhibitor on EMT-Associated Resistance to 3rd Generation EGFR-TKIs in Non-Small Cell Lung Cancer Cell Lines.

Ji W, Choi YJ, Kang MH, Sung KJ, Kim DH, Jung S, Choi CM, Lee JC, Rho JK. Ji W, et al. Among authors: kang mh. Cells. 2020 Dec 3;9(12):2596. doi: 10.3390/cells9122596. Cells. 2020. PMID: 33287368 Free PMC article.

6

Inhibition of PI3 kinase/Akt pathway is required for BMP2-induced EMT and invasion.

Kang MH, Kang HN, Kim JL, Kim JS, Oh SC, Yoo YA. Kang MH, et al. Among authors: kang hn. Oncol Rep. 2009 Sep;22(3):525-34. doi: 10.3892/or_00000467. Oncol Rep. 2009. PMID: 19639199

7

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells.

Kim DS, Na YJ, Kang MH, Yoon SY, Choi CW. Kim DS, et al. Among authors: kang mh. Korean J Intern Med. 2016 Mar;31(2):357-66. doi: 10.3904/kjim.2015.024. Epub 2016 Feb 15. Korean J Intern Med. 2016. PMID: 26874514 Free PMC article.

8

Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.

Kang MH, Choi H, Oshima M, Cheong JH, Kim S, Lee JH, Park YS, Choi HS, Kweon MN, Pack CG, Lee JS, Mills GB, Myung SJ, Park YY. Kang MH, et al. Nat Commun. 2018 May 15;9(1):1920. doi: 10.1038/s41467-018-04244-2. Nat Commun. 2018. PMID: 29765046 Free PMC article.

9

Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.

Kang S, Kim BR, Kang MH, Kim DY, Lee DH, Oh SC, Min BW, Um JW. Kang S, et al. Among authors: kang mh. PLoS One. 2018 Oct 11;13(10):e0205449. doi: 10.1371/journal.pone.0205449. eCollection 2018. PLoS One. 2018. PMID: 30308035 Free PMC article.

10

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.

Kim JH, Cha Y, Shin SJ, Park YS, Kang JH, Kim C, Lim SH, Kang MJ, Kim JG, Hwang IG, Choi JK, Shin SH, Kang SY, Lee SC, Lim ST, Kim JS, Jeung HC, Kang MH, Choi IS, Ryu HW, Lee KH, Lee MH, Lee JY, Park JH, Jeon SY, Lee N, Park CY, Kim YH. Kim JH, et al. Among authors: kang mj, kang jh, kang mh, kang sy. Anticancer Res. 2024 Jan;44(1):347-359. doi: 10.21873/anticanres.16818. Anticancer Res. 2024. PMID: 38160001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

829 results

Search Page